Tnf Pharmaceuticals, Stock Today
| TNFA Stock | 1.29 0.07 5.15% |
Performance3 of 100
| Odds Of DistressLess than 27
|
TNF Pharmaceuticals, is trading at 1.29 as of the 23rd of December 2024, a 5.15% down since the beginning of the trading day. The stock's open price was 1.36. TNF Pharmaceuticals, has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. TNF Pharmaceuticals, symbol was changed from MYMD on 24th of July 2024. The performance scores are derived for the period starting the 3rd of January 2023 and ending today, the 23rd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 23rd of January 2014 | Category Healthcare | Classification Health Care |
TNF Pharmaceuticals, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 2.37 M outstanding shares of which 279.28 K shares are at this time shorted by private and institutional investors with about 4.97 trading days to cover. More on TNF Pharmaceuticals,
Moving together with TNF Stock
Moving against TNF Stock
TNF Stock Highlights
| Older Symbol | MYMD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chief President | Mitchell MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TNF Pharmaceuticals, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand TNF Pharmaceuticals,'s financial leverage. It provides some insight into what part of TNF Pharmaceuticals,'s total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TNF Pharmaceuticals, (TNFA) is traded on NASDAQ Exchange in USA. It is located in 855 N. Wolfe Street, Baltimore, MD, United States, 21205 and employs 6 people. TNF Pharmaceuticals, was previously known as MyMD Pharmaceuticals and was traded on NASDAQ Exchange under the symbol MYMD. TNF Pharmaceuticals, is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.13 M. TNF Pharmaceuticals, conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 2.37 M outstanding shares of which 279.28 K shares are at this time shorted by private and institutional investors with about 4.97 trading days to cover.
TNF Pharmaceuticals, generates negative cash flow from operations
Check TNF Pharmaceuticals, Probability Of Bankruptcy
Ownership Allocation30% of TNF Pharmaceuticals, outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.
Check TNF Ownership Details
TNF Pharmaceuticals, Historical Income Statement
TNF Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.